Rob Hallifax
PhD MRCP BMBCh MSci
Academic Clinical Lecturer in Respiratory Medicine
Dr Hallifax is an NIHR Academic Clinical Lecturer the University of Oxford. He studied an MSc in Natural Sciences in Cambridge before training in medicine at the University of Oxford.
He won an MRC Clinical Training Fellowship for his DPhil: "Understanding Pneumothorax: epidemiology, physiology and outcomes", and published the results in JAMA and Thorax.
Dr Hallifax is the trial coordinator for RAMPP (Randomised Ambulatory Management of Primary Pneumothorax) - a multi-centre trial of 24 sites around the UK – which has now completed recruitment. He is trained in thoracoscopy, advanced pleural ultrasound and clinical trials methodology
Recent publications
-
Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the United Kingdom (POETIC) survey.
Journal article
Melhorn J. et al, (2022), The European respiratory journal
-
Cost-effectiveness of ambulatory care management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.
Journal article
Luengo-Fernandez R. et al, (2022), Thorax
-
Pneumothorax management: current state of practice in the UK.
Journal article
Hallifax RJ. et al, (2022), Respiratory research, 23
-
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial
Journal article
Psallidas I. et al, (2022), The Lancet Respiratory Medicine, 10, 139 - 148
-
Aetiology of Primary Spontaneous Pneumothorax.
Journal article
Hallifax R., (2022), Journal of clinical medicine, 11